CA9 and neoplasm: One example of this concept would be to use anti-CAIX therapy in patients undergoing anti-VEGF therapy, since CAIX expression is upregulated as a compensatory mechanism in tumours experiencing hypoxia as a result of anti-angiogenesis [80,162].